FiercePharmaMarketing will now publish every Monday and Wednesday

Rebecca Friend

We've seen remarkable growth in our readership since the launch of FiercePharmaMarketing last January. Our email readership now reaches over 30,000 pharma marketing professionals and is one of the Life Sciences group's fastest growing reports. With that growth comes higher expectations from you, the reader, and I am pleased to announce that we will be expanding our coverage to a twice-weekly email report. Starting today, you will receive FiercePharmaMarketing every Monday and Wednesday.

I hope you enjoy our added coverage. We are always interested to hear from you, our readers. Please reach out to let us know how we are doing. -- Rebecca Friend (Twitter | email)

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The U.S. aesthetics business is booming with fillers and fat freezers garnering interest, and spurring marketing campaigns, post-lockdown COVID-19.